AI-powered insights from 8-K, 6-K, 10-K and 10-Q filings with category and key takeaways
Total
0
10-K
0
10-Q
0
8-K
0
6-K
0
13F
0
Other
0
Showing 30 of 16187 summaries
Filing ID: 791949 • Apr 3, 2026, 12:40 PM ET
Scott Cooke retires as TMCC President, CEO, and Board Chairman effective April 6, 2026.
Alec Hagey appointed TMCC President, CEO, and Board Chairman effective April 6, 2026.
Cooke to serve as Executive Advisor for Toyota Financial Services Americas Oceania Region until June 30, 2026.
Toyota Motor Credit Corporation announced the retirement of President and CEO Scott Cooke effective April 6, 2026, with Alec Hagey appointed as his successor in those roles.
Filing ID: 791948 • Apr 3, 2026, 12:40 PM ET
Situs Holdings, LLC was terminated as Potomac Mills Special Servicer under the CFCRE 2016-C6 PSA.
Torchlight Loan Services, LLC was appointed as the successor Potomac Mills Special Servicer.
The servicer change was effective as of April 3, 2025.
Situs Holdings, LLC was terminated as special servicer for the Potomac Mills loan, with Torchlight Loan Services, LLC appointed as successor effective April 3, 2025.
Filing ID: 791944 • Apr 3, 2026, 12:10 PM ET
CFO Nir Sassi resigned on April 1, 2026, with no disclosed disagreement on company operations.
Qinglai Lu was appointed to the Board and Audit Committee, effective April 8, 2026, and deemed independent by Nasdaq standards.
Yu Ding was appointed as the new Chief Financial Officer, effective immediately on April 1, 2026.
Indaptus Therapeutics announced the resignation of CFO Nir Sassi and appointed Qinglai Lu to the Board and Audit Committee and Yu Ding as CFO, effective in early April 2026.
Filing ID: 791945 • Apr 3, 2026, 12:10 PM ET
1-for-150 reverse share split effective April 7, 2026 at 5:00 p.m. ET, with split-adjusted trading starting next trading day.
Pre-split: 134,835,960 Ordinary Shares outstanding as of April 2, 2026; post-split: ~898,906 shares.
New CUSIP: G2124G 203; trading continues on Nasdaq Capital Market under RDGT.
Ridgetech, Inc. announced a 1-for-150 reverse share split effective April 7, 2026, reducing outstanding Ordinary Shares from 134,835,960 to approximately 898,906 while maintaining proportional shareholder ownership.
Filing ID: 791941 • Apr 3, 2026, 12:10 PM ET
Midland Loan Services was removed as special servicer for The Essex Site 2 Mortgage Loan pursuant to Section 7.01(d) of the BMARK 2019-B14 PSA.
KeyBank National Association was appointed as the successor special servicer for the loan.
The Essex Site 2 Mortgage Loan constituted approximately 3.4% of the asset pool of the issuing entity as of its cut-off date.
KeyBank National Association was appointed as the successor special servicer for The Essex Site 2 Mortgage Loan, replacing Midland Loan Services, effective April 3, 2026.
Filing ID: 791943 • Apr 3, 2026, 12:10 PM ET
Stephen Conboy resigned as CTO effective March 31, 2026, with no disagreements on operations, policies, or practices.
90-day Transition Period (March 31 to June 30, 2026) with $10,000 monthly payments and up to $200,000 product advance.
Post-transition exclusive sales rights for specified products/systems in Tahoe area, subject to minimum sales thresholds ($500K 2026, $2M 2027+).
CitroTech Inc. entered a Transition Agreement with former CTO Stephen Conboy, effective March 31, 2026, transitioning him to CEO advisor with compensation, product sales rights, and equity provisions.
Filing ID: 791943 • Apr 3, 2026, 12:10 PM ET
Stephen Conboy resigned as CTO effective March 31, 2026, with no disagreements on operations, policies, or practices.
90-day Transition Period (March 31 to June 30, 2026) with $10,000 monthly payments and up to $200,000 product advance.
Post-transition exclusive sales rights for specified products/systems in Tahoe area, subject to minimum sales thresholds ($500K 2026, $2M 2027+).
CitroTech Inc. entered a Transition Agreement with former CTO Stephen Conboy, effective March 31, 2026, transitioning him to CEO advisor with compensation, product sales rights, and equity provisions.
Filing ID: 791942 • Apr 3, 2026, 12:10 PM ET
Potomac Mills Mortgage Loan represents approximately 5.7% of the CFCRE 2016-C6 issuing entity's asset pool as of cut-off date.
Situs Holdings, LLC removed as special servicer pursuant to Section 3.22(i) of the CFCRE 2016-C6 PSA.
Torchlight Loan Services, LLC appointed as successor special servicer for the Potomac Mills Mortgage Loan.
Situs Holdings, LLC removed as special servicer and Torchlight Loan Services, LLC appointed as successor for the Potomac Mills Mortgage Loan under the CFCRE 2016-C6 PSA, effective April 3, 2026.
Filing ID: 791940 • Apr 3, 2026, 12:00 PM ET
Torchlight Loan Services, LLC has been appointed successor special servicer for the Potomac Mills Mortgage Loan, effective April 3, 2026.
Situs Holdings, LLC was removed as special servicer under Section 3.22(i) of the CFCRE 2016-C6 PSA.
The Potomac Mills Mortgage Loan constitutes approximately 6.2% of the CFCRE 2016-C6 Mortgage Trust’s asset pool as of its cut-off date.
Effective April 3, 2026, Torchlight Loan Services, LLC replaced Situs Holdings, LLC as special servicer for the Potomac Mills Mortgage Loan—a 6.2% component of the CFCRE 2016-C6 Mortgage Trust asset pool—pursuant to Section 3.22(i) of the November 1, 2016 pooling and servicing agreement.
Filing ID: 791936 • Apr 3, 2026, 12:00 PM ET
Revenue rose 4.1% to $36.3M, driven by expansion of Nora Pharma sales efforts across Quebec, Ontario, Alberta, and British Columbia.
Gross profit increased 14.9% to $12.3M and gross margin improved to 33.8%, reflecting a decrease in cost of sales tied to lower professional allowances on sales outside Quebec.
Net cash used in operating activities improved to -$5.3M (from -$12.5M in FY2024), supported by more streamlined Nora Pharma operations and a significant decrease in the rate of inventory growth.
Sunshine Biopharma reported revenue growth of 4.1% to $36.3M in FY2025, with gross profit rising 14.9% and gross margin expanding to 33.8%, while operating and net losses widened modestly amid ongoing investment in generic pharmaceutical operations.
Filing ID: 791936 • Apr 3, 2026, 12:00 PM ET
Revenue rose 4.1% to $36.3M, driven by expansion of Nora Pharma sales efforts across Quebec, Ontario, Alberta, and British Columbia.
Gross profit increased 14.9% to $12.3M and gross margin improved to 33.8%, reflecting a decrease in cost of sales tied to lower professional allowances on sales outside Quebec.
Net cash used in operating activities improved to -$5.3M (from -$12.5M in FY2024), supported by more streamlined Nora Pharma operations and a significant decrease in the rate of inventory growth.
Sunshine Biopharma reported revenue growth of 4.1% to $36.3M in FY2025, with gross profit rising 14.9% and gross margin expanding to 33.8%, while operating and net losses widened modestly amid ongoing investment in generic pharmaceutical operations.
Filing ID: 791939 • Apr 3, 2026, 12:00 PM ET
Torchlight Loan Services, LLC has been appointed successor special servicer for the Potomac Mills Mortgage Loan, effective April 3, 2026.
Situs Holdings, LLC was removed as special servicer under Section 3.22(i) of the CFCRE 2016-C6 PSA.
The Potomac Mills Mortgage Loan constitutes approximately 4.8% of the CFCRE 2016-C6 Mortgage Trust’s asset pool as of its cut-off date.
Effective April 3, 2026, Torchlight Loan Services, LLC replaced Situs Holdings, LLC as special servicer for the Potomac Mills Mortgage Loan—a 4.8% component of the CFCRE 2016-C6 Mortgage Trust asset pool—pursuant to Section 3.22(i) of the trust’s pooling and servicing agreement.
Filing ID: 791938 • Apr 3, 2026, 12:00 PM ET
Annual and Extraordinary General Meetings are scheduled for 5 May 2026 at 11:00 a.m. CET in Luxembourg.
Shareholders of record as of 21 April 2026 will be entitled to vote at the General Meetings.
The Board proposes the re-election of directors Lakshmi Niwas Mittal, Aditya Mittal, Michel Wurth, and Etienne Schneider.
ArcelorMittal announced its Annual and Extraordinary General Meetings scheduled for 5 May 2026, including director re-elections and the nomination of Mr. Roy Harvey to the Board.
Filing ID: 791938 • Apr 3, 2026, 12:00 PM ET
Annual and Extraordinary General Meetings are scheduled for 5 May 2026 at 11:00 a.m. CET in Luxembourg.
Shareholders of record as of 21 April 2026 will be entitled to vote at the General Meetings.
The Board proposes the re-election of directors Lakshmi Niwas Mittal, Aditya Mittal, Michel Wurth, and Etienne Schneider.
ArcelorMittal announced its Annual and Extraordinary General Meetings scheduled for 5 May 2026, including director re-elections and the nomination of Mr. Roy Harvey to the Board.
Filing ID: 791938 • Apr 3, 2026, 12:00 PM ET
Annual and Extraordinary General Meetings are scheduled for 5 May 2026 at 11:00 a.m. CET in Luxembourg.
Shareholders of record as of 21 April 2026 will be entitled to vote at the General Meetings.
The Board proposes the re-election of directors Lakshmi Niwas Mittal, Aditya Mittal, Michel Wurth, and Etienne Schneider.
ArcelorMittal announced its Annual and Extraordinary General Meetings scheduled for 5 May 2026, including director re-elections and the nomination of Mr. Roy Harvey to the Board.
Filing ID: 791937 • Apr 3, 2026, 12:00 PM ET
Torchlight Loan Services, LLC has been appointed successor special servicer for the Potomac Mills Mortgage Loan, effective April 3, 2026.
Situs Holdings, LLC was removed as special servicer under Section 3.22(i) of the CFCRE 2016-C6 PSA.
The Potomac Mills Mortgage Loan constitutes approximately 2.1% of the CFCRE 2016-C6 Mortgage Trust’s asset pool as of its cut-off date.
Effective April 3, 2026, Torchlight Loan Services, LLC replaced Situs Holdings, LLC as special servicer for the Potomac Mills Mortgage Loan—a 2.1% component of the CFCRE 2016-C6 Mortgage Trust asset pool—pursuant to Section 3.22(i) of the trust’s pooling and servicing agreement.
Filing ID: 791935 • Apr 3, 2026, 11:51 AM ET
Torchlight Loan Services, LLC appointed as successor special servicer for the Potomac Mills Mortgage Loan, effective April 3, 2026.
The Potomac Mills Mortgage Loan constituted approximately 8.9% of the issuing entity's asset pool as of its cut-off date.
Torchlight has substantial experience, having resolved over $12.2 billion of U.S. commercial and multifamily loans in the past twenty-seven years.
Torchlight Loan Services, LLC was appointed as the successor special servicer for the Potomac Mills Mortgage Loan, effective April 3, 2026, following the removal of Situs Holdings, LLC.
Filing ID: 791932 • Apr 3, 2026, 11:10 AM ET
Director Steven L. Packebush retired from the board effective March 30, 2026, with no stated disagreement with the company.
Jonathan Z. Ackerman was appointed to the board as a Class 2026 director effective April 2, 2026, and will stand for reelection at the 2026 annual meeting.
The board adopted amended and restated bylaws on April 2, 2026, updating provisions related to stockholder meetings, proxy solicitations, and nomination procedures.
LSB Industries, Inc. announced the retirement of director Steven L. Packebush and the appointment of Jonathan Z. Ackerman to its board, alongside the adoption of amended and restated bylaws.
Filing ID: 791925 • Apr 3, 2026, 10:50 AM ET
Shareholders elected all eleven director nominees to the Board of Directors, with each receiving over 4.3 million 'For' votes.
The appointment of Ernst & Young LLP as the independent registered public accounting firm for fiscal year 2026 was ratified with 11.5 million 'For' votes.
The advisory vote on executive compensation was approved with 6.95 million 'For' votes, though 4.31 million broker non-votes were recorded.
McCormick & Company held its Annual Meeting of Stockholders on April 1, 2026, where shareholders elected eleven directors, ratified the appointment of Ernst & Young LLP as the independent auditor, and approved executive compensation in an advisory vote.
Filing ID: 791925 • Apr 3, 2026, 10:50 AM ET
Shareholders elected all eleven director nominees to the Board of Directors, with each receiving over 4.3 million 'For' votes.
The appointment of Ernst & Young LLP as the independent registered public accounting firm for fiscal year 2026 was ratified with 11.5 million 'For' votes.
The advisory vote on executive compensation was approved with 6.95 million 'For' votes, though 4.31 million broker non-votes were recorded.
McCormick & Company held its Annual Meeting of Stockholders on April 1, 2026, where shareholders elected eleven directors, ratified the appointment of Ernst & Young LLP as the independent auditor, and approved executive compensation in an advisory vote.
Filing ID: 791926 • Apr 3, 2026, 10:50 AM ET
Midland Loan Services was removed as special servicer of The Essex Mortgage Loan.
KeyBank National Association was appointed as the successor special servicer of The Essex Mortgage Loan.
The change is effective as of April 3, 2026.
KeyBank National Association was appointed as the successor special servicer for The Essex Mortgage Loan, effective April 3, 2026, under the Benchmark 2019-B14 Mortgage Trust agreement.
Filing ID: 791924 • Apr 3, 2026, 10:30 AM ET
Q1 2026 earnings release scheduled for Thursday, April 23, 2026 after market close.
Earnings accessible on www.SouthStateBank.com under Investor Relations, News & Market Data.
Conference call on Friday, April 24, 2026 at 9:00 a.m. ET, hosted by CFO Will Matthews.
SouthState Bank Corporation announced it will release first quarter 2026 earnings results on April 23, 2026 after market close, with a conference call the next day.
Filing ID: 791923 • Apr 3, 2026, 10:00 AM ET
Stockholders elected 12 directors to the Board for a one-year term, with all nominees receiving majority support.
Proposal to ratify Ernst & Young LLP as the independent registered public accounting firm passed with 1,143,409,866 votes for.
Stockholders approved Amendment No. 5 to the 2021 Stock Incentive Plan, increasing the share reserve by 22,000,000 shares.
At the 2026 Annual Meeting, HPE stockholders elected 12 directors, ratified EY as auditor, approved a 22-million-share increase to the Stock Incentive Plan, and approved executive compensation, while rejecting a shareholder proposal on charitable support.
Filing ID: 791921 • Apr 3, 2026, 9:50 AM ET
Board appointed Leonel Agustin Peleriti as Independent Director effective March 31, 2026.
Mr. Peleriti holds Bachelor’s in Information Systems Engineering from National University of Córdoba.
Served as Technology Solutions Analyst at Mercado Libre (2020-2023), focusing on data optimization and cloud solutions.
Global-Smart.Tech Inc. appointed Leonel Agustin Peleriti as an Independent Director effective March 31, 2026, with expertise in technology solutions and data optimization.
Filing ID: 791920 • Apr 3, 2026, 9:30 AM ET
Nasdaq notified NeuroSense on April 2, 2026 that its ordinary shares traded below $1.00 for 30 consecutive business days (Feb 18–Mar 31, 2026), violating Rule 5550(a)(2).
Nasdaq also notified NeuroSense it failed to meet the $35 million minimum market value of listed securities (MVLS) requirement under Rule 5550(b)(2) over the same 30-day period.
The Company has until September 29, 2026—a 180-calendar-day compliance period—to satisfy both requirements: 10 consecutive business days at ≥$1.00 bid price and ≥$35 million MVLS.
NeuroSense Therapeutics Ltd. received two Nasdaq non-compliance notifications on April 2, 2026—one for failing to maintain a $1.00 minimum bid price and another for falling below the $35 million minimum market value of listed securities—granting until September 29, 2026 to regain compliance.
Filing ID: 791920 • Apr 3, 2026, 9:30 AM ET
Nasdaq notified NeuroSense on April 2, 2026 that its ordinary shares traded below $1.00 for 30 consecutive business days (Feb 18–Mar 31, 2026), violating Rule 5550(a)(2).
Nasdaq also notified NeuroSense it failed to meet the $35 million minimum market value of listed securities (MVLS) requirement under Rule 5550(b)(2) over the same 30-day period.
The Company has until September 29, 2026—a 180-calendar-day compliance period—to satisfy both requirements: 10 consecutive business days at ≥$1.00 bid price and ≥$35 million MVLS.
NeuroSense Therapeutics Ltd. received two Nasdaq non-compliance notifications on April 2, 2026—one for failing to maintain a $1.00 minimum bid price and another for falling below the $35 million minimum market value of listed securities—granting until September 29, 2026 to regain compliance.
Filing ID: 791916 • Apr 3, 2026, 9:10 AM ET
Forian entered into a definitive merger agreement on April 2, 2026, for an all-cash acquisition by a consortium led by CEO Max Wygod, taking the company private.
Stockholders will receive $2.17 per share in cash, representing a 22.6% premium to the unaffected closing price as of August 22, 2025.
The transaction is valued at approximately $68 million in equity and is not subject to a financing condition, with funding committed by the consortium.
Forian Inc. entered into a definitive merger agreement on April 2, 2026, for an all-cash acquisition by a consortium led by its CEO, which will take the company private at $2.17 per share.
Filing ID: 791919 • Apr 3, 2026, 9:10 AM ET
Dr. Youdinghuan Chen appointed independent director, joining audit, compensation, and nominating committees, and designated compensation committee chairperson.
Mr. Zhongwei Wang designated as audit committee chairperson.
Ms. Josephine Yan Yeung resigned as independent director.
Intelligent Group Limited appointed Dr. Youdinghuan Chen as independent director and compensation committee chair, designated Mr. Zhongwei Wang as audit committee chair, and accepted resignations of Ms. Josephine Yan Yeung and Ms. Sha Ye, effective April 3, 2026.
Filing ID: 791918 • Apr 3, 2026, 9:10 AM ET
Director Daniel Schurr resigned from the CHS Board effective March 30, 2026, creating a vacancy.
Schurr's resignation was due to accepting a board seat at Nationwide Mutual Insurance Company.
Schurr had served on the CHS Board since 2006 and was Chair from 2017 to December 2025.
CHS Inc. director Daniel Schurr resigned from the board effective March 30, 2026, after serving since 2006 and as Chair from 2017 to December 2025, to join the board of Nationwide Mutual Insurance Company.
Filing ID: 791918 • Apr 3, 2026, 9:10 AM ET
Director Daniel Schurr resigned from the CHS Board effective March 30, 2026, creating a vacancy.
Schurr's resignation was due to accepting a board seat at Nationwide Mutual Insurance Company.
Schurr had served on the CHS Board since 2006 and was Chair from 2017 to December 2025.
CHS Inc. director Daniel Schurr resigned from the board effective March 30, 2026, after serving since 2006 and as Chair from 2017 to December 2025, to join the board of Nationwide Mutual Insurance Company.